Objetivo
Driven by clinical applications and MNT and IST technology, SmartHEALTH will develop an open integrated architecture for new biodiagnostic systems to support European companies exploiting bioassays or new application concepts. Initial system has a disposable fluidic cartridge with a desktop basestation linking to the ambient eHealth environment - health cards, patient data, online services. This concept will be miniaturised and cost engineered into a portable and consumer product. It will perform multianalyate sensing and interpretation, for nucleic acids, proteins and others and will handle multiple biological sample types.
Results will be interpreted and presented using bioinformatics. Systems will be healthcare user identity and ambient environment aware, respecting confidentiality and information access rights. The IP will enable enhanced medical diagnosis, leading to earlier and more precise results contributing to an increased quality of life as well as increasing the competitiveness of the European IVD sector. The IP will include: selection of probes, sample preparation, fluid handling, concentration, filtering; sensors and transducers, (label free systems and rapid nucleic acid detection systems); surface modification/integration of nanoscale elements; system development - controllers, actuators, data processing, communications and integration with ambient intelligence, on-line information services; understanding of fit to healthcare, input to medical management - user factors, costs, approvals, regulations, ethics.
Clinical areas are in Cancer Diagnostics - breast cancer recurrence monitoring, cervical cancer case finding, colorectal cancer - diagnostic/theranostic/prognostics. Each application includes clinical validation and commercial exploitation partners. The consortium is a powerful set of 3 Universities, 9 Research Institutions, 10 SMEs, 4 larger Companies and 4 Clinical Groups covering all the relevant issues.
Ámbito científico
- natural sciencesbiological sciencesbiochemistrybiomoleculesnucleic acids
- social scienceseconomics and businessbusiness and managementcommercee-commerce
- medical and health sciencesclinical medicineoncologybreast cancer
- medical and health sciencesclinical medicineoncologycolorectal cancer
- medical and health sciencesclinical medicineoncologycervical cancer
Palabras clave
Convocatoria de propuestas
Data not availableRégimen de financiación
IP - Integrated ProjectCoordinador
NE1 7RU NEWCASTLE UPON TYNE
Reino Unido
Ver en el mapa
Participantes (30)
2007 NEUCHATEL
Ver en el mapa
10117 BERLIN
Ver en el mapa
GLASNEVIN, DUBLIN 9
Ver en el mapa
76133 KARLSRUHE
Ver en el mapa
80686 MUENCHEN
Ver en el mapa
07743 JENA
Ver en el mapa
41455 GOTEBORG
Ver en el mapa
48170 ZAMUDIO
Ver en el mapa
48150 SONDIKA
Ver en el mapa
48903 CRUCES/BARAKALDO
Ver en el mapa
20014 DONOSTIA - SAN SEBASTIAN
Ver en el mapa
20500 ARRASATE - MONDRAGON
Ver en el mapa
55129 MAINZ
Ver en el mapa
3001 LEUVEN
Ver en el mapa
TW1 4JX TWICKENHAM MIDDLESEX
Ver en el mapa
07745 JENA
Ver en el mapa
3179 SCORESBY, VICTORIA
Ver en el mapa
414 58 GOTEBORG
Ver en el mapa
2628 VK DELFT
Ver en el mapa
11020 ARNAD
Ver en el mapa
01006 VITORIA - GASTEIZ
Ver en el mapa
7465 TRONDHEIM
Ver en el mapa
413 46 GOTEBORG
Ver en el mapa
20123 MILANO
Ver en el mapa
2007 NEUCHATEL
Ver en el mapa
UNDEFINED
Ver en el mapa
43003 TARRAGONA
Ver en el mapa
TRENTO
Ver en el mapa
80331 MUENCHEN
Ver en el mapa
SN2 2QW SWINDON, WILTSHIRESWINDON WILTSHIRE
Ver en el mapa